Chadi Nabhan, Chief Medical Officer and Head of Strategy at Ryght, shared a post on X:
“Recently, ODAC voted “NO” on approving Blenrep 4 R/R Myeloma. In a back-to-back HUExpress, I get Vincent Rajkumar thoughts on that decision and I also host Greg to give us “behind the scenes” on what happened that day at ODAC.
Two must watch EPs coming your way this week.”
Proceed to the video attached to the post.
More posts featuring Chadi Nabhan on OncoDaily.